Literature DB >> 23649019

Transplantation: Alloantibodies in simultaneous liver-kidney transplantation.

Andrew L Singer1, Dorry L Segev.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23649019     DOI： 10.1038/nrneph.2013.84

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients.

Authors:  M Olausson; L Mjörnstedt; G Nordén; L Rydberg; J Mölne; L Bäckman; S Friman
Journal:  Am J Transplant       Date:  2007-01       Impact factor: 8.086

2.  Acute humoral rejection in an ABO compatible combined liver-kidney transplant--the kidney is not always protected.

Authors:  T W Reichman; S R Marino; J Milner; R C Harland; A Cochrane; J M Millis; G Testa
Journal:  Am J Transplant       Date:  2009-06-12       Impact factor: 8.086

3.  High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

Authors:  J G O'Leary; H Kaneku; B M Susskind; L W Jennings; M A Neri; G L Davis; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

4.  Class II alloantibody and mortality in simultaneous liver-kidney transplantation.

Authors:  J G O'Leary; H M Gebel; R Ruiz; R A Bray; J D Marr; X J Zhou; S M Shiller; B M Susskind; A D Kirk; G B Klintmalm
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

5.  Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.

Authors:  W Dar; A Agarwal; C Watkins; H M Gebel; R A Bray; K E Kokko; T C Pearson; S J Knechtle
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

6.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

7.  Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival.

Authors:  A Rasmussen; H F Davies; N V Jamieson; D B Evans; R Y Calne
Journal:  Transplantation       Date:  1995-03-27       Impact factor: 4.939

8.  Combined liver-kidney transplants: allosensitization and recipient outcomes.

Authors:  Medhat Askar; Jesse D Schold; Bijan Eghtesad; Stuart M Flechner; Bruce Kaplan; Lynne Klingman; Nizar N Zein; John Fung; Titte R Srinivas
Journal:  Transplantation       Date:  2011-06-15       Impact factor: 4.939

9.  Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.

Authors:  Marcela Castillo-Rama; Maria Jose Castro; Ivan Bernardo; Juan Carlos Meneu-Diaz; Almudena Moreno Elola-Olaso; Sara M Calleja-Antolin; Eva Romo; Pablo Morales; Enrique Moreno; Estela Paz-Artal
Journal:  Liver Transpl       Date:  2008-04       Impact factor: 5.799

10.  Impact of human leukocyte antigen matching in liver transplantation.

Authors:  Ulf P Neumann; Olaf Guckelberger; Jan M Langrehr; Martina Lang; Volker Schmitz; Tom Theruvath; Constanze Schonemann; Stephan Menzel; Jochen Klupp; Peter Neuhaus
Journal:  Transplantation       Date:  2003-01-15       Impact factor: 4.939
  10 in total
  1 in total

1.  Intra-operative kinetics of anti-HLA antibody in simultaneous liver-kidney transplantation.

Authors:  M Kueht; P Jindra; H L Stevenson; T N Galvan; B Murthy; J Goss; J Anton; R Abbas; M F Cusick
Journal:  Mol Genet Metab Rep       Date:  2021-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.